期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Cardiovascular Therapeutics LetPub Score 6.2
50 ratings
Rate
Reputation 7.5 Influence 4.8 Speed 8.4 | ||||||||||||||||||||||||
期刊簡稱 | CARDIOVASC THER | ||||||||||||||||||||||||
ISSN | 1755-5914 | ||||||||||||||||||||||||
E-ISSN | 1755-5922 | ||||||||||||||||||||||||
h-index | 39 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 0.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | https://www.hindawi.com/journals/cdtp | ||||||||||||||||||||||||
在線稿件提交 | https://mc.manuscriptcentral.com/cdr | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Wiley-Blackwell Publishing Ltd | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | UNITED STATES | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 2008 | ||||||||||||||||||||||||
每年文章數 | 34每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 99.28% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q2
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1755-5914%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: Average 6 Month(s) | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: About 95% | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Cardiovascular Therapeutics] 的評論 | 撰寫評論 |
作者: 狮吼冬冬 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2023-10-20 10:49:17 評論於 How long does it take to get a response? It's been pending for five weeks~(0) 讚! | 狮吼冬冬 |
作者: 绮烟mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-06 19:02:38 評論於 Assigned, the reviewers have been looking for 10 days and still haven't found it(0) 讚! | 绮烟mio |
作者: Yehudi More 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-12-05 15:05:20 評論於 Isn't this normal? Once it's divided, it'll be quick(0) 讚! | Yehudi More |
作者: 绮烟mio 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-11-11 18:19:31 評論於 How long does it take to allocate?(0) 讚! | 绮烟mio |
作者: 深渊学林 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-23 23:41:04 評論於 Have you been assigned an editor? It's been 12 days and I still haven't been assigned an editor(0) 讚! | 深渊学林 |
作者: xzj2022 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-09-07 09:06:14 評論於 Is this journal invitation only? Why can't I find a submission section? After logging in, it shows "This site only accepts invited submissions."(0) 讚! | xzj2022 |
作者: 北国东硕 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2022-06-19 08:21:21 評論於 Heavy research focus: Cardiovascular experience sharing: It's been 5 days since submission, and the editor hasn't been assigned yet. Is this situation common?(0) 讚! | 北国东硕 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 20:18:10 評論於 The number of corresponding authors for SCI journal papers is not necessarily limited to one, and there is no fixed standard. This is because different SCI journals have different policies regarding the number of corresponding authors. For SCI journals that only accept one corresponding author, if multiple corresponding authors are listed on a paper, the first corresponding author will be automatically selected as the corresponding author. For SCI journals that accept two corresponding authors, two corresponding authors can be listed. The same applies to other requirements, meaning that the number of corresponding authors listed by the authors must comply with the regulations of the target SCI journal. The first author of an SCI paper is the person who has made the greatest contribution to the experiments and writing of the paper and is the person whose name appears first in the list of authors. However, in cases where multiple authors collaborate, it is common to have multiple first authors. There is no clear regulation regarding the number of co-first authors, and this is largely dependent on factors such as the workload of the paper, its length, the regulations of the publishing journal, and the recognition of the authors’ institutions. In general, it is common for an SCI paper to have 2-4 first authors(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 10:35:48 評論於 The corresponding author is the overall responsible person for the research project, responsible for the project's funding, design, writing of articles, and quality control, and responsible for communication with journals during submission, peer review, and the entire publication process(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 深渊兴业 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 10:28:04 評論於 How many corresponding authors/first authors can a journal have?(0) 讚! | 深渊兴业 |
作者: 陶宜三岁啦 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 12:21:51 評論於 What is a corresponding author?(0) 讚! | 陶宜三岁啦 |
作者: 重阳振安 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-08-25 08:47:52 評論於 How long until we start seeing results?(0) 讚! | 重阳振安 |
作者: Rodney Toby 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-10-19 09:37:34 評論於 Research focus: Cardiovascular Experiences: pending approval for nearly 2 weeks with no response(0) 讚! | Rodney Toby |
作者: 巴蜀彦露 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2020-03-24 10:40:50 評論於 Is pure basic research acceptable?(0) 讚! | 巴蜀彦露 |
作者: 北国安阳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-12-24 22:28:47 評論於 I submitted it on October 8th, and received a reply email at the end of October urging for the draft. There was no email reply last Thursday urging for the draft. Now I see the comments and I am very worried!(0) 讚! | 北国安阳 |
作者: 青曼酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-11-15 19:43:45 評論於 Is the magazine going to close down? Not only have there been no updates for nearly five months, but there hasn't been a new article on the magazine's homepage for several months. Are they on a six-month break?(0) 讚! | 青曼酱大魔王 |
作者: 缠丝博泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-18 23:10:33 評論於 How long does it take for them to include my submission? I didn't realize that my article for 2019 couldn't be searched after half a day of submission. I also don't understand what's going on with this journal(0) 讚! | 缠丝博泽 |
作者: 缠丝博泽 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-09-18 14:05:06 評論於 Currently, no articles from 2019 can be retrieved(0) 讚! | 缠丝博泽 |
作者: Saxon Sophy 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-08-11 16:07:45 評論於 Delay in submission(0) 讚! | Saxon Sophy |
作者: 青曼酱大魔王 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-07-31 21:44:53 評論於 Is the acceptance rate really only 11%?(0) 讚! | 青曼酱大魔王 |
作者: 终幕志永 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-23 22:18:23 評論於 Review speed: 2.0 | Submission acceptance rate: 50.0 Experience sharing: Quarterly, the review process is currently a bit slow. If you are in a hurry, we suggest submitting to another journal(0) 讚! | 终幕志永 |
作者: Valiant 領域: 医学 審稿時間: 5.0 month(s) 結果: 待定&不明 撰寫評論 |
2019-01-23 17:30:44 評論於 Quarterly, now reviewing a bitSlow, more anxious, it is recommended to change to other journals..(0) 讚! | Valiant |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-18 10:56:40 評論於 On the rise, optimistic about the future, what do you all think?(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2013-07-01 10:11:05 評論於 This journal is now rated 2.5, which is a significant increase from last year. Is there a possibility of reaching 3 points?(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 08:30:39 評論於 Research Focus: Cardiovascular(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us